Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts

The mechanisms of skin rejection in vascularized composite allotransplantation (VCA) remain incompletely understood. The formation of tertiary lymphoid organs (TLO) in hand transplantation has been recently described. We assess this phenomenon in experimental and clinical VCA rejection. Skin biopsies of human (n = 187), nonhuman primate (n = 11), and rat (n = 15) VCAs were analyzed for presence of TLO. A comprehensive immunohistochemical assessment (characterization of the cell infiltrate, expression of adhesion molecules) including staining for peripheral node addressin (PNAd) was performed and correlated with rejection and time post‐transplantation. TLO were identified in human, nonhuman primate, and rat skin samples. Expression of PNAd was increased in the endothelium of vessels upon rejection in human skin (P = 0.003) and correlated with B‐ and T‐lymphocyte numbers and LFA‐1 expression. PNAd expression was observed at all time‐points after transplantation and increased significantly after year 5. In nonhuman primate skin, PNAd expression was found during inflammatory conditions early and late after transplantation. In rat skin, PNAd expression was strongly associated with acute rejection and time post‐transplantation. Lymphoid neogenesis and TLO formation can be uniformly found in experimental and human VCA. PNAd expression in vascular endothelium correlates with skin rejection and T‐ and B‐cell infiltration.

[1]  S. Schneeberger,et al.  Antibody‐mediated rejection in hand transplantation , 2014, Transplant international : official journal of the European Society for Organ Transplantation.

[2]  Elbert E Vaca,et al.  Histopathology of Chronic Rejection in a Nonhuman Primate Model of Vascularized Composite Allotransplantation , 2013, Transplantation.

[3]  G. Pierer,et al.  The Innsbruck Hand Transplant Program: An Update More than a Decade after the First Transplant: 1233 , 2012 .

[4]  R. Margreiter,et al.  Histopathologic characterization of mild rejection (grade I) in skin biopsies of human hand allografts , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[5]  M. Goddard,et al.  Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  E. Rodriguez,et al.  Nonhuman Primate Model of Fibula Vascularized Composite Tissue Allotransplantation Demonstrates Donor-Recipient Bony Union , 2011, Plastic and reconstructive surgery.

[7]  G. Pierer,et al.  World experience after more than a decade of clinical hand transplantation: update on the Innsbruck program. , 2011, Hand clinics.

[8]  Y. Kuo,et al.  An Optimized Dual-Surgeon Simultaneous Orthotopic Hind-Limb Allotransplantation Model in Rats , 2011, Journal of Reconstructive Microsurgery.

[9]  S. Schneeberger,et al.  Achievements and challenges in composite tissue allotransplantation , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[10]  O. Thaunat.  Pathophysiologic Significance of B-Cell Clusters in Chronically Rejected Grafts , 2011, Transplantation.

[11]  E. Rodriguez,et al.  Vascularized Bone Marrow‐Based Immunosuppression Inhibits Rejection of Vascularized Composite Allografts in Nonhuman Primates , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  R. Écochard,et al.  Chronic Rejection Triggers the Development of an Aggressive Intragraft Immune Response through Recapitulation of Lymphoid Organogenesis , 2010, The Journal of Immunology.

[13]  R. Margreiter,et al.  Molecular Markers and Targeted Therapy of Skin Rejection in Composite Tissue Allotransplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  A. Thomson,et al.  Composite Tissue Vasculopathy and Degeneration Following Multiple Episodes of Acute Rejection in Reconstructive Transplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  S. Keshavjee,et al.  The Role of Intrapulmonary De Novo Lymphoid Tissue in Obliterative Bronchiolitis after Lung Transplantation1 , 2009, The Journal of Immunology.

[16]  Christina L Kaufman,et al.  A new option for amputees: transplantation of the hand. , 2009, Journal of rehabilitation research and development.

[17]  A. Kirk,et al.  The Banff 2007 Working Classification of Skin‐Containing Composite Tissue Allograft Pathology , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  J. Michel,et al.  B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy , 2008, Transplantation.

[19]  Frédéric Schuind,et al.  The International Registry on Hand and Composite Tissue Transplantation , 2010, Transplantation.

[20]  R. Margreiter,et al.  First Forearm Transplantation: Outcome at 3 Years , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  Fadi G Lakkis,et al.  Tertiary Lymphoid Tissues Generate Effector and Memory T Cells That Lead to Allograft Rejection , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  R. Margreiter,et al.  Status 5 Years after Bilateral Hand Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[23]  F. Aloisi,et al.  Lymphoid neogenesis in chronic inflammatory diseases , 2006, Nature Reviews Immunology.

[24]  J. Michel,et al.  Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Fadi G Lakkis,et al.  Lymphoid Neogenesis in Murine Cardiac Allografts Undergoing Chronic Rejection , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  M. Fukuda,et al.  Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Cupedo,et al.  Induction of secondary and tertiary lymphoid structures in the skin. , 2004, Immunity.

[28]  P. Laakkonen,et al.  Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. , 2004, Journal of the American Society of Nephrology : JASN.

[29]  K. Chandy,et al.  Molecular Properties and Physiological Roles of Ion Channels in the Immune System , 2001, Journal of Clinical Immunology.

[30]  R. Jonsson,et al.  Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. , 2003, Arthritis and rheumatism.

[31]  W. Lesslauer,et al.  Ectopic LTαβ Directs Lymphoid Organ Neogenesis with Concomitant Expression of Peripheral Node Addressin and a HEV-restricted Sulfotransferase , 2003, The Journal of experimental medicine.

[32]  C. Weyand,et al.  Ectopic lymphoid organogenesis: a fast track for autoimmunity. , 2001, The American journal of pathology.

[33]  M. Juan,et al.  Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. , 2001, The American journal of pathology.

[34]  T. Paavonen,et al.  De novo induction of endothelial L-selectin ligands during kidney allograft rejection. , 2000, Journal of the American Society of Nephrology : JASN.

[35]  M. Nieminen,et al.  Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting human heart transplants. , 1999, The American journal of pathology.

[36]  S. Rosen,et al.  Commentary Endothelial Ligands for L-Selectin From Lymphocyte Recirculation to Allograft Rejection , 1999 .

[37]  T. Springer,et al.  High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. , 1995, Immunology today.

[38]  S. Hemmerich,et al.  Sulfation-dependent recognition of high endothelial venules (HEV)- ligands by L-selectin and MECA 79, and adhesion-blocking monoclonal antibody , 1994, The Journal of experimental medicine.